# Study of PWT33597 Mesylate in Subjects With Advanced Malignancies

> **NCT01407380** · PHASE1 · COMPLETED · sponsor: **Pathway Therapeutics, Inc.** · enrollment: 22 (actual)

## Conditions studied

- Malignancies

## Interventions

- **DRUG:** PWT33597 mesylate

## Key facts

- **NCT ID:** NCT01407380
- **Lead sponsor:** Pathway Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2012-08
- **Final completion:** 2012-09
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2012-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01407380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01407380, "Study of PWT33597 Mesylate in Subjects With Advanced Malignancies". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01407380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*